LabStyle Innovations Corp. Executes Distribution Partnership with GEMCO Medical
Expands Reach to Pharmacies and Durable Medical Dealers Access on Commercial Health Plans Boston, MA – July 21, 2016 –LabStyle Innovations … Read more
LabStyle Reports 100%-Plus Monthly Growth in U.S. Users Since Launch
Direct-to-Consumer Digital Marketing Strategy Driving Rapid Initial Market Penetration Boston, MA – July 19, 2016 – LabStyle Innovations (NASDAQ: DRIO) … Read more
LabStyle Innovations Joins College Diabetes Network (CDN)
Dario Smart Diabetes Management Solution to reach thousands of college students across the U.S. Boston, MA – July 11, … Read more
LabStyle Innovations to Present at Upcoming Investor Conferences
Caesarea, Israel, May 27, 2016 — LabStyle Innovations Corp. (NASDAQ:DRIO), developer of the Dario™ Diabetes Management Tool, today announced that … Read more
LabStyle Innovations Reports Q1 2016 Results
84% increase in sequential quarterly revenues Quarterly gross loss narrowed 61% compared to Q4 2015 Net loss narrowed by 29% … Read more
LabStyle Innovations Granted Key Patent in Europe Relating to the Dario™ Diabetes Management Tool
Caesarea, Israel, May 5, 2016 — LabStyle Innovations Corp. (NASDAQ:DRIO), developer of the Dario™ Diabetes Management Tool, today announced … Read more
LabStyle Innovations Corp. (Nasdaq: DRIO) to Ring The Nasdaq Stock Market Closing Bell
ADVISORY, March 23, 2016 (GLOBE NEWSWIRE) — What: LabStyle Innovations Corp. (Nasdaq:DRIO), developer of the Dario™ Blood Glucose Monitoring System, … Read more
LabStyle Innovations’ Dario Blood Glucose Monitoring System online e-store and membership program live in USA
World’s largest glucose monitoring market gets user-centric mHealth product that brings diabetes management into the digital age CAESAREA, Israel, March … Read more
LabStyle Innovations Granted U.S. Patent Expanding IP for Fluids Testing into Industrial Applications via Mobile Devices and Apps
Broadens platform technology’s applications beyond mHealth and into health and non-health related industrial markets CAESAREA, Israel, March 9, 2016 /PRNewswire/ … Read more
LabStyle Innovations Announces Uplisting to NASDAQ and Capital Raise of $8.5 Million
Company Effects a 1-for-18 Reverse Stock Split CAESAREA, Israel March 4, 2016 /PRNewswire/ –LabStyle Innovations Corp. (DRIO), developer of the … Read more
LabStyle Innovations Reports 2015 Results
• FDA clearance announced on December 22nd • 61% increase in sequential quarterly shipments • Q4 2015 net loss … Read more
LabStyle Innovations to Launch Dario Blood Glucose Monitoring System in the U.S. in Q1 2016
Sales channels to include direct-to-consumer, e-commerce, third-party distributors Establishing North American headquarters and warehouse to serve U.S. and Canada CAESAREA, … Read more
LabStyle Innovations Receives U.S. FDA Marketing Clearance for the Dario Blood Glucose Monitoring System
Smartphone-based blood glucose monitor with unique all-in-one design cleared for launch in the world’s largest diabetes market CAESAREA, Israel, December … Read more
Dario Diabetes Management Solution Garners Global Media Coverage
CAESAREA, Israel, December 16, 2015 /PRNewswire/ — LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today … Read more
Investment From Existing Shareholders and Private Investors
A LabStyle distributor participated in the investment CAESAREA, Israel, November 19, 2015 /PRNewswire/ — LabStyle Innovations Corp. (DRIO), developer of the … Read more
LabStyle Innovations’ Leadership in Mobile Health Featured in Facebook Case Study
Mobile healthcare apps and social media become platform for user-centric revolution enabling people to take charge of their health CAESAREA, … Read more
LabStyle Innovations Reports Third Quarter 2015 Results
– 56% increase in sequential quarterly revenues – Net loss narrowed by 41% compared to Q3 2014 – Rapid market … Read more
LabStyle Innovations’ Dario Diabetes Management Solution to Launch in India Through Distribution Agreement with Centaur Pharmaceuticals
Centaur, one of India’s leading healthcare companies, to offer Dario in a region where over 66 million people live with … Read more
LabStyle Innovations Reports Dario Blood Glucose Monitor Demonstrates Over 99% Accuracy in New Study
Reported in poster presentation at Diabetes Technology Meeting on October 22 and 23, 2015 CAESAREA, Israel, October 29, 2015 /PRNewswire/ … Read more
LabStyle Innovations to Report New Data at Diabetes Technology Meeting On October 22 and 23, 2015
CAESAREA, Israel, October 15, 2015 /PRNewswire/ — LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today … Read more